JAKARTA - The Food and Drug Supervisory Agency (BPOM) is assisting 15 researches on herbal medicines that can be used for additional COVID-19 therapy in support of efforts to deal with COVID-19 in the country. as an addition or adjuvant to COVID-19 therapy, with varying progress of course from each of these studies," said Head of the Food and Drug Supervisory Agency (BPOM) Penny Kusumastuti Lukito in the Webinar Series of Opportunities for Development of Natural Medicines towards Standardized Herbal Medicines and Innovative Phytopharmaceuticals in Indonesia. Jakarta, reported by Antara, Wednesday, October 13. During the COVID-19 pandemic, Penny said that the discovery of natural medicines was also a priority for various studies carried out for the handling of COVID-19. She explained that the 15 studies consisted of two studies with clinical trial status. has been completed and is in the process of being registered, seven studies with moderate research process status In progress, two studies are still in the process of assisting the preparation of clinical trial protocols, and four studies are in the process of preclinical testing stages.
In addition, said Penny, there are also 68 other studies related to the handling of COVID-19 that are being assisted by BPOM. Upstream assistance, he said, was carried out during research and development, starting from the preparation of clinical trial protocols to conducting clinical trials in accordance with the principles and test methods. BPOM also provides various trainings, such as training on good clinical trials and various simplifications of flexibility in the process of conducting clinical trials and the registration process. said Penny.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
